Greenwich LifeSciences, Inc. (GLSI)

Greenwich LifeSciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 18, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Cap	372	148	135	195	320	463
Market Cap Growth	180.85%	9.28%	-30.79%	-38.95%	-30.95%	-
Enterprise Value	368.6	143.61	128.17	181.82	292.68	434.64
Last Close Price	26.88	11.23	10.52	15.20	24.33	36.47
PE Ratio	-	-9.28	-15.25	-24.92	-69.51	-182.35
PB Ratio	169.70	58.29	20.17	14.78	11.92	16.77
P/TBV Ratio	164.03	57.68	20.17	14.86	11.74	12.54
P/FCF Ratio	-	-20.33	-20.86	-31.50	-74.54	-401.83
P/OCF Ratio	-	-20.33	-20.86	-31.50	-74.54	-401.83
EV/EBITDA Ratio	-	-8.97	-13.75	-22.62	-63.71	-233.65
EV/EBIT Ratio	-	-8.97	-13.74	-22.61	-63.66	-233.20
EV/FCF Ratio	-	-19.76	-19.78	-29.33	-68.20	-376.97
Net Debt / Equity Ratio	-1.74	-1.61	-1.04	-1.02	-1.01	-1.04
Net Debt / EBITDA Ratio	0.19	0.26	0.75	1.68	5.92	15.41
Net Debt / FCF Ratio	0.44	0.56	1.08	2.17	6.34	24.86
Quick Ratio	2.35	2.62	23.74	51.23	70.63	27.41
Current Ratio	2.35	2.62	23.74	51.23	70.63	27.41
Return on Equity (ROE)	-825.41%	-341.95%	-89.30%	-39.08%	-16.78%	-14.18%
Return on Assets (ROA)	-495.83%	-288.80%	-91.13%	-39.52%	-16.45%	-12.99%
Return on Invested Capital (ROIC)	1714.67%	2244.62%	4031.34%	3828.04%	1018.40%	265.27%
Return on Capital Employed (ROCE)	-830.13%	-346.78%	-93.68%	-40.16%	-16.88%	-14.18%
Earnings Yield	-5.23%	-10.77%	-6.56%	-4.01%	-1.44%	-0.55%
FCF Yield	-	-4.92%	-4.79%	-3.17%	-1.34%	-0.25%
Buyback Yield / Dilution	-3.05%	-1.30%	0.51%	0.23%	-36.27%	-320.69%
Total Shareholder Return	-3.05%	-1.30%	0.51%	0.23%	-36.27%	-320.69%

Updated Nov 14, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q